Hugo Harrod

Hugo Harrod

London

Hugo joined MVM in 2005. Before joining MVM, he qualified as a chartered accountant with KPMG. Hugo has a degree in Molecular and Cellular Biochemistry from Oxford University.

Hugo is a member of the boards of AccuVein, Inc., Vertos Medical, Inc. and eZono AG.

He was previously a director of Horizon Discovery Limited (LSE: HZD) and Vantia Limited and led MVM's investment into BioVex Limited (acquired by Amgen).

MVM

Email
hh@mvm.com

London Office
MVM Partners LLP
30 St George Street
London
W1S 2FH

Companies